Baird Medical Investment Holdings Ltd - Ordinary Share (BDMD)
Healthcare › Surgical & Medical Instruments & Apparatus
Price History
Feb 9, 2026 — May 3, 2026Investment Snapshot
- Trading 36% below Graham Number ($2.79) — significant margin of safety
- Piotroski F-Score 1/9 — signs of financial weakness
- Loss-making — negative ROE of -87.0%
- Revenue declining 39% annually
Baird Medical Investment Holdings Ltd - Ordinary Share (BDMD) is a Healthcare company operating in Surgical & Medical Instruments & Apparatus, listed on the NASDAQ , with a market capitalisation of $73 million . Key value metrics: P/E ratio 5.1, P/B ratio 2.34, Piotroski F-Score 1 out of 9 .
Value Score
Key Metrics
Current vs 5-Year Average
Based on 3 years of SEC filingsRevenue & Net Income
Financial Statements
| Metric | FY22 | FY23 | FY24 |
|---|---|---|---|
| Revenue | $X.XB | $X.XB | $X.XB |
| Gross Profit | $X.XB | $X.XB | $X.XB |
| Operating Income | $X.XB | $X.XB | $X.XB |
| Net Income | $X.XB | $X.XB | $X.XB |
| EBITDA | $X.XB | $X.XB | $X.XB |
| Total Assets | $X.XB | $X.XB | $X.XB |
| Total Liabilities | $X.XB | $X.XB | $X.XB |
Baird Medical Investment Holdings Ltd - Ordinary Share — Fundamental Analysis Summary
Baird Medical Investment Holdings Ltd - Ordinary Share (BDMD) is trading 36% below its Graham Number of $2.79 — a significant margin of safety by Benjamin Graham's standard. The stock carries a low trailing P/E ratio of 5.1x.
On financial health, BDMD shows a weak Piotroski F-Score of 1/9, a signal of deteriorating financial health, and negative return on equity of -87.0% (sector average: -20.6%), and minimal leverage with a debt-to-equity ratio of 0.28.
StockPik's composite Value Score for BDMD is 57/100 — an above-average value rating. The score is built from ten fundamental signals: P/E, P/B, PEG ratio, P/S ratio, return on equity, gross margin, debt-to-equity, current ratio, dividend yield, and Piotroski F-Score.
BDMD reports a high gross margin of 83.8% (sector average: 40.1%) and a negative operating margin of -113.7%.
BDMD shows revenue declining at 39% year-over-year, with earnings declining at 319%.